Skip to search formSkip to main contentSkip to account menu

EM703

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Erythromycin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
EM703, A NEW DERIVATIVE OF ERYTHROMYCIN, INHIBITS TRANSFORMING GRWTH FACTOR-β SIGNALING IN HUMAN LUNG FIBROBLASTS
Long-term, low-dose macrolide therapy has been proven to improve survival in patients with diffuse panbronchiolitis and cystic… 
2008
2008
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
2006
2006
Three-dimensional solution structure of EM703 with potent promoting activity of monocyte-to-macrophage differentiation.
2005
2005
Macrolides with Promotive Activity of Monocyte to Macrophage Differentiation
AbstractWe have been interested in the immunomodulatory effect, to promote differentiation of the human monocytic cell line THP-1… 
2004
2004
[Effect of EM703, a new macrolide derivative, on mucus secretion from the airway epithelial cells].
2004
2004
[Action of EM703, a new macrolide derivative, on immune-responsive cells (macrophages and lymphocytes)].
2004
2004
[Action of EM703 on bleomycin-induced pulmonary fibrosis in mice].
2004
2004
[Action of EM703, a new macrolide derivative, on the lung that has been damaged by influenza virus].
2004
2004
[Effect of EM703, a new macrolide derivative, on activation of transcription factors derived from the airway epithelial cells].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)